Chem. J. Chinese Universities ›› 2018, Vol. 39 ›› Issue (10): 2185.doi: 10.7503/cjcu20180181

• Analytical Chemistry • Previous Articles     Next Articles

Preparation of a Targeted Tumor Nanocomposites for Combined Photodynamic-photothermal Therapy Based on Partially Reduced Graphene Oxide

WANG Xueli1,2, WANG Zhenxin2,*()   

  1. 1. Grain College, Jilin Business and Technology College, Changchun 130507, China
    2. State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry Chinese Academy of Science, Changchun 130022, China
  • Received:2018-02-07 Online:2018-09-29 Published:2018-09-29
  • Contact: WANG Zhenxin E-mail:wangzx@ciac.ac.cn
  • Supported by:
    † Supported by the National Science Foundation of China(Nos.21475126, 21775145).

Abstract:

Partially reduced grphene oxide(pRGO) is synthesized using a mild reduction method by incubating GO suspension under alkaline condition at room tempeature. Aptamer(AS1411) non-covalent binding with cardiogreen(ICG), a photosensitizer and photothermal effect molecule, to the surface of pRGO, was used to target cancer cells for photodynamic therapy(PDT) and photothermal therapy(PTT). Structure and morphology of the as-synthesized pRGO and pRGO-AS1411-ICG(pRAI) nanocomposites were confirmed by menas of FTIR, Raman, XPS, UV-Vis, transmission electron microscopy(TEM) and energy dispersive spectrometer(EDS). pRAI targets cancer cells with AS1411 to produce singlet oxygen for PDT and photothermal effect for PTT upon near-infrared(NIR) light irradiation. Since pRGO is decorated with several AS1411-ICG molecules, the pRGO-AS1411-ICG conjugate yields enhanced binding and therapeutic effect by the added ability to carry multiple photosensitizers. Consequently, pRAI offers a remarkably improved and synergistic therapeutic effect on cells.

Key words: Partially reduced graphene oxide, Nanocomposite, Photothermal therapy, Photodynamic therapy, Tumor cell

CLC Number: 

TrendMD: